Found 13 matching trials
Combination Therapy for PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma: A Bayesian Adaptive Phase II Trial
PHASE2This is a prospective, Bayesian adaptive, phase II clinical trial designed ...
Location
Cancer Center of Guangzhou Medical University
Pre-Operative Treatment in REseCTable COlon CanceR
PHASE3This is an open-label, randomized, controlled, multicenter, phase III study...
Location
Charité Universitätsmedizin Berlin
Mesenchymal Stem Cells in the Treatment of Refractory Primary Immune Thrombocytopenia
NAThis study is a clinical study initiated by single-arm, single-center, mult...
Location
Dongguan Taixin Hospital
Proteinuria in Renal Transplant Patients Treated With Dapagliflozin
NAThe prevalence of chronic kidney disease is rising steadily and represents ...
Location
University Hospital of Montpellier
BREntuximab Vedotin in SEcond LIne Therapy BEfore Transplant
PHASE2A Randomized Phase IIb Study, Evaluating Efficacy of Salvage Therapy with B...
Location
Institut Català D'Oncologia - Hospital Germans Trias I Pujol
Smart Discharges to Improve Post-discharge Health Outcomes in Children
NAIn Uganda, about 5% of children discharged after hospitalization for a seri...
Location
BC Children's Hospital Research Institute
Effect of Adalimumab for the Treatment of Uveitis in Juvenile Idiopathic Arthritis
PHASE2The investigators propose to study the efficacy of adalimumab versus placeb...
Location
Hospital of necker Enfants malades
Orelabrutinib Combined With Obinutuzumab and Short-Course Venetoclax in Patients With Treatment-Naïve Mantle Cell Lymphoma (MCL)
PHASE2This study aims to evaluate the safety and efficacy of orelabrutinib (O) in...
Location
Changzhou Second People's Hospital
Donor-derived Cell-free DNA in Kidney Transplant Recipients
N/ADonor-derived cell-free DNA (dd-cfDNA) is a promising non-invasive biomarke...
Location
Institute for Clinical and Experimental Medicine
Re-Radiochemotherapy and Pembrolizumab vs. Immuno(Chemo)Therapy for Locoregionally Recurrent PD-L1 Positive (CPS≥1) HNSCC
PHASE3Prospective, open-label, randomized controlled phase III trail that aims to...
Location
Klinikum Chemnitz gGmbH, Klinik für Radioonkologie